AROMICS - one of the winners of Chemostart V Edition Program

by AROMICS

The Insud Pharma group has announced the winners of the V edition of its ChemoStart programme. The biotech companies Aromics and MiMark Diagnostics, based in the Barcelona Science Park, together with ...

Read more

AROMICS among the top 40 companies to invest in Europe

by AROMICS

​InvestHorizon is a programme financed by the European Commission, in association with Eureka, to facilitate series A funding for selected deep tech companies boosting their investment readiness and...

Read more

Aromics launches a ‘crowdfunding’ campaign to accelerate the development of a novel drug for the treatment of asbestos-related cancer

by AROMICS

The financial round of 300,000€ is oriented towards private investors who are interested in acquiring equity in the company through the European biotechnology crowdfunding platform CapitalCell who h...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream